🌻We’re preparing #TumorBoardTuesday!

🧑‍🔬Join Dr Maryam Lustberg & Dr Adriana Kahn 08.01.23 8pm ET, for a walk through TNBC tx while pt on IS for #Crohns

🌻Don’t miss this essential MDT chat!

🧠Grab FREE #CME credits
👉🏽Visit integrityce.com/TBT2023 for more info

@JohnEbbenMDPhD @MPishvaian #OncoDon #PrecisionMedicine #Oncology #IBD #PrecisionOncology #BreastCancer #Cancer

🔥 #TumorBoardTuesday is a must-attend!

🧑‍🔬Join @marklewismd @CatherineaOC 07.25.23 8pm ET as they explore differentiating midgut & #PNETs

🔥Be part of an insightful discussion!

🧠Get FREE #CME credits as we finalize the case
👉🏽Visit integrityce.com/TBT2023 for more info #OncoDon #GastroDon

#PrecisionMedicine #Oncology #Pancreas #NETs
#NeuroendocrineTumor @MPishvaian @JohnEbbenMDPhD @EmpoweringPts9 @tumorboard @tumor

RT @TumorBoardTues
It's ALMOST time for the #TumorBoardTuesday case wrap up. We apologize for the delay, but promise it will be worth it!

Check back Saturday for our exclusive interview w @RachelRiechelm2 as we talk implications of hypermutation in #NET- don't miss it! https://twitter.com/i/web/status/1654634595868987394

It's ALMOST time for the #TumorBoardTuesday case wrap up. We apologize for the delay, but promise it will be worth it!

Check back Saturday for our exclusive interview w @RachelRiechelm2 as we talk implications of hypermutation in #NET- don't miss it! https://twitter.com/i/web/status/1654634595868987394

RT @TumorBoardTues
Thank you to @jessrzanotti & @RachelRiechelm2 for an exceptional #TumorBoardTuesday on hypermutation in #NET- how might this change care in the future?

Check out thread below & answer the question at the end to get free #CME!

Special edition of Case Wrap Up drops tomorrow!💡 https://twitter.com/jessrzanotti/status/1653555761094557697

Thank you to @jessrzanotti & @RachelRiechelm2 for an exceptional #TumorBoardTuesday on hypermutation in #NET- how might this change care in the future?

Check out thread below & answer the question at the end to get free #CME!

Special edition of Case Wrap Up drops tomorrow!💡
---
RT @jessrzanotti
@TumorBoardTues @RachelRiechelm2 @MPishvaian @JohnEbbenMDPhD @PamelaKunzMD @marklewismd @DianeReidyLagun @timpawlik @CanHealeu @duiliorocha_…
https://twitter.com/jessrzanotti/status/1653555761094557697

RT @TumorBoardTues
Thank you 🙏🏼for a thought-provoking & useful #TumorBoardTuesday!!

Look for Case Wrap Up🎀Thursday 05/04/23

📅 Please mark your calendar for Tuesday 05/09 at 8pm ET when @PGrivasMDPhD @rafee_ralukder join us to chat Cisplatin-ineligible mUC treatment

RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass (body/tail)
🔬Liver bx + NET G2 Ki67 12%
🩻PET-Ga + uptake in pancreas & liver (SUVs>20)
💉1L: Lanreotide SC - DP liver after 1y (⬆️volume)
🤨What 2L tx?

RT @jessrzanotti
@TumorBoardTues 2/15 #TumorBoardTuesday

👩🏻 starts 2L CAPTEM: major partial response🙏🏼
🔪Pancreatectomy + R0 liver resections
🔬Path: NET G3 Ki67 90%

🗓️2 mo later
back pain + weight loss: large retroperitoneal LN
💉3L: rechallenge CAPTEM ➡️ poor clinical control 🔀 Cisplatin + Etoposide

RT @TumorBoardTues
@jessrzanotti #TumorBoardTuesday Images for tweet 2/15

RT @jessrzanotti
@TumorBoardTues 3/15 #TumorBoardTuesday #NETCancer @RachelRiechelm2 @MPishvaian @JohnEbbenMDPhD

👩🏻 DP mediastinal LN after 6 mo
💉4L: FOLFIRINOX with partial response/severe toxicity
📑NGS (Foundation One): very high TMB 97 MSS

🧐What 5L tx would you pick?

RT @jessrzanotti
@TumorBoardTues @RachelRiechelm2 @MPishvaian @JohnEbbenMDPhD 4/15 #TumorBoardTuesday #NETCancer
Due to findings👆🏽

💉 Systemic therapy modified to Pembrolizumab

See image for full biomarker assay

RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass (body/tail)
🔬Liver bx + NET G2 Ki67 12%
🩻PET-Ga + uptake in pancreas & liver (SUVs>20)
💉1L: Lanreotide SC - DP liver after 1y (⬆️volume)
🤨What 2L tx?

RT @jessrzanotti
@TumorBoardTues 2/15 #TumorBoardTuesday

👩🏻 starts 2L CAPTEM: major partial response🙏🏼
🔪Pancreatectomy + R0 liver resections
🔬Path: NET G3 Ki67 90%

🗓️2 mo later
back pain + weight loss: large retroperitoneal LN
💉3L: rechallenge CAPTEM ➡️ poor clinical control 🔀 Cisplatin + Etoposide

RT @TumorBoardTues
@jessrzanotti #TumorBoardTuesday Images for tweet 2/15

RT @jessrzanotti
@TumorBoardTues 3/15 #TumorBoardTuesday #NETCancer @RachelRiechelm2 @MPishvaian @JohnEbbenMDPhD

👩🏻 DP mediastinal LN after 6 mo
💉4L: FOLFIRINOX with partial response/severe toxicity
📑NGS (Foundation One): very high TMB 97 MSS

🧐What 5L tx would you pick?

RT @jessrzanotti
@TumorBoardTues @RachelRiechelm2 @MPishvaian @JohnEbbenMDPhD 4/15 #TumorBoardTuesday #NETCancer
Due to findings👆🏽

💉 Systemic therapy modified to Pembrolizumab

See image for full biomarker assay

RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass (body/tail)
🔬Liver bx + NET G2 Ki67 12%
🩻PET-Ga + uptake in pancreas & liver (SUVs>20)
💉1L: Lanreotide SC - DP liver after 1y (⬆️volume)
🤨What 2L tx?

RT @jessrzanotti
@TumorBoardTues 2/15 #TumorBoardTuesday

👩🏻 starts 2L CAPTEM: major partial response🙏🏼
🔪Pancreatectomy + R0 liver resections
🔬Path: NET G3 Ki67 90%

🗓️2 mo later
back pain + weight loss: large retroperitoneal LN
💉3L: rechallenge CAPTEM ➡️ poor clinical control 🔀 Cisplatin + Etoposide

RT @TumorBoardTues
@jessrzanotti #TumorBoardTuesday Images for tweet 2/15